Annual General Meeting Archive
Dear shareholders,
The situation regarding the coronavirus (COVID-19) remains uncertain and therefore unfortunately once more it does not allow us to hold the Annual General Meeting (AGM) in the conventional way.
In accordance with the Swiss Federal Council’s COVID-19 Ordinance 3, the Board of Directors of Basilea Pharmaceutica Ltd. has decided to hold the 2022 AGM without the physical presence of shareholders. The Board of Directors has taken this decision with great regret, but it considers this measure necessary to protect the health of shareholders and everyone involved in the AGM.
Accordingly, shareholders can exercise their shareholder rights via the Independent Proxy only. Detailed information as to how to give voting instructions to the Independent Proxy (in writing or electronically through the e-voting platform) can be found in the “Organizational Notes” included in the invitation, which is made available for download below. For additional information, please also see the shareholder letter, which is availble for download below.
Leonard Kruimer has been determined by the Board of Directors to be independent; the Board applied the independence criteria of the Swiss Code of Best Practice for Corporate Governance and international best practice standards, including the Classification of Directors (European Policy) by ISS.
Dear shareholders,
Unfortunately, the current situation regarding the coronavirus (COVID-19) does not allow us to hold the Annual General Meeting (AGM) in the conventional way.
In accordance with the ordinance issued by the Swiss Federal Council (COVID-19 Ordinance 3, extended until December 31, 2021) and the protective measures against the coronavirus that currently apply, the Board of Directors of Basilea Pharmaceutica Ltd has therefore decided with great regret to hold the 2021 Annual General Meeting without the physical presence of shareholders. For additional information please see the documents below.
The invitation including the agenda items and information on how to exercise your voting rights at the AGM are made available for download below.
If you need support with registration/proxy voting of your shares you may contact Computershare directly at business.supportcomputersharech.
Additional information:
An English translation of the protocol is available at no cost upon request from Basilea Investor Relations.
Additional information:
An English translation of the protocol is available at no cost upon request from Basilea Investor Relations.
Additional information:
An English translation of the protocol is available at no cost upon request from Basilea Investor Relations.